Serigene LLC, a developer of a PCR-based diagnostic testing platform, has appointed James Horan, CPA, MBA to the Company's Board of Directors. "We are pleased to welcome James Horan to our Board of Directors," commented Sergey Ilyin, PhD, Chief Scientific Officer of Serigene. “James Horan extensive financial experience in a variety of industries combined with his deep business and M&A experience will provide Serigene with valuable perspectives as our company grows”.
About James Horan, CPA, MBA
James Horan, CPA, MBA, is the Chief Operating and Financial Officer for the Pennsylvania Biotechnology Center, Institute for Hepatitis and Virus Research and the Hepatitis B Foundation. He was a co-founder of LScan Technologies, Inc., and was responsible for directing the financial, operational and strategic functions of the corporation prior to its acquisition. As a seasoned financial executive, he was responsible for directing and executing a comprehensive range of accounting, financial and operating functions including financial report preparation, investment analysis, cash management, tax planning and strategic planning.
James has held previous positions with Deloitte & Touche, Katz Capital and LScan Technologies, Inc. (Start-up). In addition to his auditing and financial compliance experience, James is also an Adjunct Professor in the LaSalle University Graduate School Program, lecturing courses in Mergers & Acquisitions, Investment Analysis and Portfolio Management, and Financial Statement Analysis.
He is a Certified Public Accountant and a graduate of LaSalle with a BS in Finance and Accounting and an MBA in Finance. James is a member of the American Institute of Certified Public Accountants, the Association for Financial Professionals, the Association for Corporate Growth – Philadelphia Chapter, and also holds memberships in the American Accounting Association and the American Management Association.
About Serigene LLC
Serigene was founded to introduce a rigorous and cutting edge standard in field-testing to the diagnostic community. Serigene has developed a proprietary point of care integrated testing technology consisting of a Real Time PCR reader (RT-reader) with a proprietary Serigene cartridge. The Serigene cartridge has significant advantage over alternatives in terms of flexibility, number of tests, and detection speed. More information about Serigene can be found at the company website at www.serigene.com